gefitinib has been researched along with Myeloproliferative Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, XM; Li, Y; Zhang, LY | 1 |
1 other study(ies) available for gefitinib and Myeloproliferative Disorders
| Article | Year |
|---|---|
[Inhibitory effect of gefitinib and lapatinib on proliferation of HEL cells].
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Gefitinib; Humans; Janus Kinase 2; Lapatinib; Mutation; Myeloproliferative Disorders; Protein Kinase Inhibitors; Quinazolines | 2012 |